Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network ...

Evolent Health Inc . (NYSE:EVH) stock has reached its 52-week low, trading at $9.55, marking a significant downturn for the company within the healthcare sector. Despite the current market ...

In the latest quarter, 16 analysts provided ratings for Evolent Health (NYSE:EVH), showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings ...

Throughout the last three months, 18 analysts have evaluated Evolent Health EVH, offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of their ...

In this article, we are going to take a look at where Evolent Health, Inc. (NYSE:EVH) stands against other stocks that insiders are buying in March. As President Donald Trump’s on-again ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.

Truist analyst Jailendra Singh lowered the firm’s price target on Evolent Health (EVH) to $14 from $15 and keeps a Buy rating on the shares as ...

Explore Evolent Health stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for EVH. Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Thursday, shares of Evolent Health Inc (Symbol: EVH) entered into oversold territory, hitting an RSI reading ...

In a report released today, Jailendra Singh from Truist Financial maintained a Buy rating on Evolent Health (EVH – Research Report). The ...